Zhitong Finance App News, Hengrui Pharmaceutical (01276.HK) issued an announcement. Recently, the company's subsidiary Chengdu Shengdi Pharmaceutical Co., Ltd. received a notice from the State Drug Administration to approve the registration and listing of drugs produced in the company's domestic production of orteconazole capsules.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.